Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Novartis Investigative Site, Burlington

Novartis Investigative Site, New Brunswick

Novartis Investigative Site, New Hyde Park

Novartis Investigative Site, Philadelphia

Novartis Investigative Site, Philadelphia

Novartis Investigative Site, Richmond

Novartis Investigative Site, Norfolk

Novartis Investigative Site, Winston-Salem

Novartis Investigative Site, Charleston

Novartis Investigative Site, Atlanta

Novartis Investigative Site, Gainesville

Novartis Investigative Site, Orlando

Novartis Investigative Site, Miami

Novartis Investigative Site, Tampa

Novartis Investigative Site, Nashville

Novartis Investigative Site, Jackson

Novartis Investigative Site, Ypsilanti

Novartis Investigative Site, Grand Rapids

Novartis Investigative Site, Iowa City

Novartis Investigative Site, Sioux Falls

Novartis Investigative Site, Billings

Novartis Investigative Site, Chicago

Novartis Investigative Site, Kansas City

Novartis Investigative Site, Omaha

Novartis Investigative Site, New Orleans

Novartis Investigative Site, Little Rock

Novartis Investigative Site, Oklahoma City

Novartis Investigative Site, Dallas

Novartis Investigative Site, Tyler

Novartis Investigative Site, Austin

Novartis Investigative Site, Boise

Novartis Investigative Site, Salt Lake City

Novartis Investigative Site, Los Angeles

Novartis Investigative Site, Bellflower

Novartis Investigative Site, Fullerton

Novartis Investigative Site, Madera

Novartis Investigative Site, Detroit

Novartis Investigative Site, Spokane

Novartis Investigative Site, Anchorage

Novartis Investigative Site, Hartford

Novartis Investigative Site, New Haven

Novartis Investigative Site, Stamford

Novartis Investigative Site, Indianapolis

Novartis Investigative Site, Boston

Novartis Investigative Site, Lebanon

Novartis Investigative Site, Akron

Novartis Investigative Site, Hershey